top of page
Media & Events
Nov 8, 2024
House Commission IX of the Republic of Indonesia Commends Phyto-pharmaceutical Production Facility and Advocates for Inclusion of Indigenous Modern Medicines in National Health Insurance
In an effort to bolster the resilience and quality of the national pharmaceutical industry, the House of Representatives Commission IX, led
Sep 28, 2024
Visit to Dexa Site Cikarang: BPOM Head Affirms Support for OMAI in JKN
The Head of the Indonesian Food and Drug Authority (BPOM), Mr. Taruna Ikrar, conducted a working visit to Dexa Site Cikarang
Jun 4, 2024
Ensuring the Quality of Dexa Group Medicines: Indonesian Society of Neurosurgeons Visits DLBS and DSCM
The Central Board of the Indonesian Society of Neurosurgeons (PERSPEBSI) visited the Dexa Laboratories of Biomolecular Sciences (DLBS)
Apr 23, 2024
Prof. Raymond Tjandrawinata, The Pioneer of Indonesia’s Indigenous Modern Medicine, Ranks Among The Top Three Pharmaceutical Scientists
Prof. Raymond Tjandrawinata of Dexa Group has achieved third place among the top pharmaceutical scientists in Indonesia
Mar 26, 2024
Head of RSPAD Visits Dexa Group Facilities, Supports the Use of OMAI Phytopharmaceuticals for National Health Independence
Dexa Group welcomed the visit of the Head of the Gatot Soebroto Central Army Hospital (Rumah Sakit Pusat Angkatan Darat (RSPAD)), Lieutenant
Jun 23, 2023
Ministry of Health Affirms Commitment to Increasing Phytopharmaceuticals Usage
The government is committed to achieving national pharmaceutical independence, one of which is through the development of natural-based...
bottom of page